A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into patients to fight cancer and HIV, addressing a major limitation of current treatments. Their findings, published today in Science Advances, describe a manufacturing approach that, compared to the existing process, generates longer-lasting immune cells that provide more sustained control of human blood cancers and suppression of HIV-infection in mouse models.

Scientists in Sweden and the U.S. today reported the first-ever direct observation a type of short‑lived molecule that has shaped decades of thinking in atmospheric chemistry, combustion research and biomedical science.

 

Publishing in Science Advances, researchers from KTH Royal Institute of Technology, in Stockholm, and Kinetic Chemistry Research in Mountain View, California, say their discovery of long-theorized, oxygen-rich tetroxides has implications in a number of sciences, including atmospheric chemistry, biochemistry and medicine and combustion chemistry.

BUFFALO, NY — March 13, 2026 — A new research paper was published in Volume 18 of Aging-US on March 2, 2026, titled “D, L-Buthionine-(S, R)-sulfoximine recapitulates the anti-obesity effects of sulfur amino acid restriction without the associated deleterious effects on bone in male mice.”